# Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

> **NCT06289452** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **InnoVec Biotherapeutics Inc.** · enrollment: 18 (estimated)

## Conditions studied

- Retinoschisis
- Retinal Disease
- Retinal Degeneration
- Eye Diseases

## Interventions

- **GENETIC:** IVB102 Injection
- **GENETIC:** IVB102 Injection
- **GENETIC:** IVB102 Injection

## Key facts

- **NCT ID:** NCT06289452
- **Lead sponsor:** InnoVec Biotherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289452, "Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06289452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*